230 related articles for article (PubMed ID: 35699208)
21. Wnt/β-catenin signaling via Axin2 is required for myogenesis and, together with YAP/Taz and Tead1, active in IIa/IIx muscle fibers.
Huraskin D; Eiber N; Reichel M; Zidek LM; Kravic B; Bernkopf D; von Maltzahn J; Behrens J; Hashemolhosseini S
Development; 2016 Sep; 143(17):3128-42. PubMed ID: 27578179
[TBL] [Abstract][Full Text] [Related]
22. Novel Allosteric Effectors Targeting Human Transcription Factor TEAD.
Ibrahim MT; Verkhivker GM; Misra J; Tao P
Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37240355
[TBL] [Abstract][Full Text] [Related]
23. Structural insights into the YAP and TEAD complex.
Li Z; Zhao B; Wang P; Chen F; Dong Z; Yang H; Guan KL; Xu Y
Genes Dev; 2010 Feb; 24(3):235-40. PubMed ID: 20123905
[TBL] [Abstract][Full Text] [Related]
24. A splicing isoform of TEAD4 attenuates the Hippo-YAP signalling to inhibit tumour proliferation.
Qi Y; Yu J; Han W; Fan X; Qian H; Wei H; Tsai YH; Zhao J; Zhang W; Liu Q; Meng S; Wang Y; Wang Z
Nat Commun; 2016 Jun; 7():ncomms11840. PubMed ID: 27291620
[TBL] [Abstract][Full Text] [Related]
25. A Non-canonical Role of YAP/TEAD Is Required for Activation of Estrogen-Regulated Enhancers in Breast Cancer.
Zhu C; Li L; Zhang Z; Bi M; Wang H; Su W; Hernandez K; Liu P; Chen J; Chen M; Huang TH; Chen L; Liu Z
Mol Cell; 2019 Aug; 75(4):791-806.e8. PubMed ID: 31303470
[TBL] [Abstract][Full Text] [Related]
26. TEAD1 regulates cell proliferation through a pocket-independent transcription repression mechanism.
Li F; Negi V; Yang P; Lee J; Ma K; Moulik M; Yechoor VK
Nucleic Acids Res; 2022 Dec; 50(22):12723-12738. PubMed ID: 36484096
[TBL] [Abstract][Full Text] [Related]
27. Dissection of the interaction between the intrinsically disordered YAP protein and the transcription factor TEAD.
Mesrouze Y; Bokhovchuk F; Meyerhofer M; Fontana P; Zimmermann C; Martin T; Delaunay C; Erdmann D; Schmelzle T; Chène P
Elife; 2017 Apr; 6():. PubMed ID: 28430104
[TBL] [Abstract][Full Text] [Related]
28. The Hippo effector YAP1/TEAD1 regulates EPHA3 expression to control cell contact and motility.
Al-Mathkour MM; Dwead AM; Alp E; Boston AM; Cinar B
Sci Rep; 2022 Mar; 12(1):3840. PubMed ID: 35264657
[TBL] [Abstract][Full Text] [Related]
29. The SWI/SNF complex is a mechanoregulated inhibitor of YAP and TAZ.
Chang L; Azzolin L; Di Biagio D; Zanconato F; Battilana G; Lucon Xiccato R; Aragona M; Giulitti S; Panciera T; Gandin A; Sigismondo G; Krijgsveld J; Fassan M; Brusatin G; Cordenonsi M; Piccolo S
Nature; 2018 Nov; 563(7730):265-269. PubMed ID: 30401838
[TBL] [Abstract][Full Text] [Related]
30. c-Abl antagonizes the YAP oncogenic function.
Keshet R; Adler J; Ricardo Lax I; Shanzer M; Porat Z; Reuven N; Shaul Y
Cell Death Differ; 2015 Jun; 22(6):935-45. PubMed ID: 25361080
[TBL] [Abstract][Full Text] [Related]
31. A Sveinsson's chorioretinal atrophy-associated missense mutation in mouse Tead1 affects its interaction with the co-factors YAP and TAZ.
Kitagawa M
Biochem Biophys Res Commun; 2007 Oct; 361(4):1022-6. PubMed ID: 17689488
[TBL] [Abstract][Full Text] [Related]
32. YAP1-TEAD1 signaling controls angiogenesis and mitochondrial biogenesis through PGC1α.
Mammoto A; Muyleart M; Kadlec A; Gutterman D; Mammoto T
Microvasc Res; 2018 Sep; 119():73-83. PubMed ID: 29680477
[TBL] [Abstract][Full Text] [Related]
33. Effects of the hippo signaling pathway in human gastric cancer.
Zhou GX; Li XY; Zhang Q; Zhao K; Zhang CP; Xue CH; Yang K; Tian ZB
Asian Pac J Cancer Prev; 2013; 14(9):5199-205. PubMed ID: 24175801
[TBL] [Abstract][Full Text] [Related]
34. NF2 deficiency accelerates neointima hyperplasia following vascular injury via promoting YAP-TEAD1 interaction in vascular smooth muscle cells.
Sun X; Li S; Gan X; Chen K; Yang D; Yang Y
Aging (Albany NY); 2020 May; 12(10):9726-9744. PubMed ID: 32422606
[TBL] [Abstract][Full Text] [Related]
35. VGLL4 and MENIN function as TEAD1 corepressors to block pancreatic β cell proliferation.
Li F; Liu R; Negi V; Yang P; Lee J; Jagannathan R; Moulik M; Yechoor VK
Cell Rep; 2023 Jan; 42(1):111904. PubMed ID: 36662616
[TBL] [Abstract][Full Text] [Related]
36. Retinal Degeneration Triggers the Activation of YAP/TEAD in Reactive Müller Cells.
Hamon A; Masson C; Bitard J; Gieser L; Roger JE; Perron M
Invest Ophthalmol Vis Sci; 2017 Apr; 58(4):1941-1953. PubMed ID: 28384715
[TBL] [Abstract][Full Text] [Related]
37. Regulation of Hippo pathway transcription factor TEAD by p38 MAPK-induced cytoplasmic translocation.
Lin KC; Moroishi T; Meng Z; Jeong HS; Plouffe SW; Sekido Y; Han J; Park HW; Guan KL
Nat Cell Biol; 2017 Jul; 19(8):996-1002. PubMed ID: 28752853
[TBL] [Abstract][Full Text] [Related]
38. Effect of the acylation of TEAD4 on its interaction with co-activators YAP and TAZ.
Mesrouze Y; Meyerhofer M; Bokhovchuk F; Fontana P; Zimmermann C; Martin T; Delaunay C; Izaac A; Kallen J; Schmelzle T; Erdmann D; Chène P
Protein Sci; 2017 Dec; 26(12):2399-2409. PubMed ID: 28960584
[TBL] [Abstract][Full Text] [Related]
39. Alpha-fetoprotein upregulates hepatocellular carcinoma cell-intrinsic PD-1 expression through the LATS2/YAP/TEAD1 pathway.
Leng G; Gong H; Liu G; Kong Y; Guo L; Zhang Y
Biochim Biophys Acta Gen Subj; 2024 May; 1868(5):130592. PubMed ID: 38395204
[TBL] [Abstract][Full Text] [Related]
40. Discovery of a new class of reversible TEA domain transcription factor inhibitors with a novel binding mode.
Hu L; Sun Y; Liu S; Erb H; Singh A; Mao J; Luo X; Wu X
Elife; 2022 Nov; 11():. PubMed ID: 36398861
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]